PHENERGAN VC Drug Patent Profile
✉ Email this page to a colleague
When do Phenergan Vc patents expire, and when can generic versions of Phenergan Vc launch?
Phenergan Vc is a drug marketed by Ani Pharms and is included in two NDAs.
The generic ingredient in PHENERGAN VC is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENERGAN VC?
- What are the global sales for PHENERGAN VC?
- What is Average Wholesale Price for PHENERGAN VC?
Summary for PHENERGAN VC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Clinical Trials: | 17 |
| DailyMed Link: | PHENERGAN VC at DailyMed |
Recent Clinical Trials for PHENERGAN VC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Colorado, Denver | Phase 4 |
| University of Florida | Phase 4 |
| South Valley University | Phase 1 |
US Patents and Regulatory Information for PHENERGAN VC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | PHENERGAN VC | phenylephrine hydrochloride; promethazine hydrochloride | SYRUP;ORAL | 008604-003 | Apr 2, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | PHENERGAN VC W/ CODEINE | codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride | SYRUP;ORAL | 008306-005 | Apr 2, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
